EVMN
Evommune, Inc.
stockNYSE
At CloseOct 2, 2026 3:59:56 PM EDT
6.89USD-4.172%(-0.30)1,745,397
Pre-marketOct 2, 2026 9:29:30 AM EDT
7.12USD-0.974%(-0.07)
After-hoursOct 2, 2026 4:48:30 PM EDT
6.97USD+1.161%(+0.08)
Loading…
Loading…
249.51M
Previous Close
$7.21
Beta
0.98
52-Week High
$33.20 2026-02-10
52-Week Low
$6.74 2026-10-02
SMA 50
$11.67
SMA 200
$18.94
Avg. Vol 10D
904,679
Avg. Vol 30D
753,179
Avg. Vol 90D
795,052
Relative Vol
2.32
36.29M
19.21M
52.92%
2,876,209
14.98%
3.32
55%/45%
35.68%
16.56%
0.6100%
1,600,000
379
1,983
5,581
Oct 1, 2026
Evommune presents Phase 2a atopic dermatitis trial data · 
Investing.com
Sep 18, 2026
Cantor Fitzgerald reiterates Evommune stock rating at Overweight · Investing.com
Sep 16, 2026
EVMN Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 8.39 | 2026-09-28 | -18.06% | -4.302 |
| 1M | 12.27 | 2026-09-04 | -43.97% | 0.932 |
| 3M | 12.36 | 2026-07-06 | -44.38% | 2.169 |
| 6M | 24.58 | 2026-04-06 | -72.03% | 0.579 |
| 1Y | 20.23 | 2025-11-06 | -66.02% | 0.978 |
EVMN Stock Summary
Evommune, Inc. (NYSE:EVMN) stock price today is $6.88, and today's volume is 1,745,474. EVMN is down 4.646% today. The 30 day average volume is 753,179. EVMN market cap is $249.51M with 36.29M shares outstanding.